C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge.
about
Selected new developments in asbestos immunotoxicityAlveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation.The role of CXC chemokines in pulmonary fibrosis.Chemokines: extracellular messengers for all occasions?Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammationAmniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavageIL-9 protects against bleomycin-induced lung injury: involvement of prostaglandins.Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout mice.Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration.Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibitionRespiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytesCigarette smoke, inflammation, and lung injury: a mechanistic perspective.New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease.Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.N-acetylcysteine amide, a thiol antioxidant, prevents bleomycin-induced toxicity in human alveolar basal epithelial cells (A549).Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease.The role of p53 in bleomycin-induced DNA damage in the lung. A comparative study with the small intestine.Synergistic neutrophil elastase-cytokine interaction degrades collagen in three-dimensional culture.Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappaB and AP-1.Bleomycin treatment causes enhancement of virus replication in the lungs of SHIV-infected macaques.CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants.Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome.Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice.Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts.Number 2 Feibi Recipe Reduces PM2.5-Induced Lung Injury in Rats.
P2860
Q23923096-B3D49177-675E-4ABC-ACCD-648FDDA7A676Q30306117-2FA93BBE-9BD6-40A6-A126-5E14E67C1DE5Q30308011-B3B458A9-7774-4ABE-A107-8101E01B59D6Q30443091-82561086-B1D3-46FC-9C16-ABCF8FF6BA0FQ33539653-0406316D-31EB-4C60-BF50-62E9DDEC2088Q34434772-7E24281A-6853-4ECF-AFDE-6ACDB9947DD3Q34964361-9A8237DA-5949-4C6E-B7BE-4FA8A22A60E8Q35083565-748BF230-98AC-4C08-9672-B52F1E3BD5ADQ35570365-554D51C3-BE56-4F12-B3F4-507B5C1B97A8Q35570990-C0B160DF-E54A-46B0-BF8A-B0284C3666FEQ35781428-B96EAB25-B9B3-4040-A09C-E11A46532CABQ35786037-61444310-E64F-43D6-95EC-04607F47F730Q35792214-326DFE96-2283-43B8-9B50-1964770B5C5BQ37360552-B233D869-21F6-49E1-A1B9-184A44FDACB0Q37415404-B3BAB70A-E8E1-425E-9352-E31B86FE5F75Q37954366-E8F1BAFD-8101-4BE4-937B-E67064C74E3DQ39134299-1CA8D204-1E16-4614-9510-51C597FC200FQ40666861-2D2C803D-CF65-4975-9852-DE5A9133A39DQ42048854-57241FF0-28BF-485B-87FA-E6548409FBF9Q43737973-36078F8A-6335-48CF-BF39-F359C2991FB3Q43988479-DE93683E-2E89-46C5-8806-F37D46A899C9Q45408337-FDDA2E64-036D-450C-96AF-12FB1154DF05Q47256226-0A171452-6302-451B-9FC1-49D552341627Q47443642-02AE0C2F-F9D8-4F16-B7CB-652FFD0EDAF4Q51689652-4D4DA27A-BCA9-4ECD-9F2B-BC4DF6456C57Q54101319-0CAA0F15-CC66-4654-B026-4E3780CA6D00Q54114121-1D8CAF35-D7D0-46DA-B34B-DC36EF273B83Q54288740-BAA2F646-0071-4F34-A446-2CAB78A880D7Q55208572-D2C216A8-EA78-4C10-B6C4-2A44B912AC6D
P2860
C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
C-C chemokines: novel mediator ...... sponse to bleomycin challenge.
@en
type
label
C-C chemokines: novel mediator ...... sponse to bleomycin challenge.
@en
prefLabel
C-C chemokines: novel mediator ...... sponse to bleomycin challenge.
@en
P2093
P1476
C-C chemokines: novel mediator ...... sponse to bleomycin challenge.
@en
P2093
P304
P356
10.1165/AJRCMB.15.6.8969262
P577
1996-12-01T00:00:00Z